Walleye Capital’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Walleye Capital’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-109,674	Closed	-$37.3K	–	6151
2024 Q1	$37.3K	Hold	109,674	–	–	﹤0.01%	4769
2023 Q4	$22.2K	Sell	109,674 -91,044	-45%	-$19K	﹤0.01%	4456
2023 Q3	$33.1K	Sell	200,718 -98,807	-33%	-$22.8K	﹤0.01%	4294
2023 Q2	$46.2K	Hold	299,525	–	–	﹤0.01%	3657
2023 Q1	$29.3K	Hold	299,525	–	–	﹤0.01%	3322
2022 Q4	$18K	Buy	+299,525	New	+$24.5K	﹤0.01%	2677

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 36.38% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Walleye Capital's AONCW Position: Q2 2024 in Review

Walleye Capital sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 109,674 shares — an estimated $37.3K sold.

Walleye Capital first reported a position in AONCW in Q4 2022 and held it in 6 quarters. The position peaked at $46.2K in Q2 2023. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Walleye Capital reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 109,674 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $37.3K.
Walleye Capital first reported a position in American Oncology Network, Inc. Warrant in Q4 2022 and held it in 6 quarters.
Walleye Capital's American Oncology Network, Inc. Warrant position peaked at $46.2K in Q2 2023.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.